DPHARMA (7148.KL)
2.41 -0.090 (-3.60%)
Company Name | DUOPHARMA BIOTECH BERHAD | ||
---|---|---|---|
Volume | 1,042,300 | Prev Close (LACP) | 2.500 |
Open | 2.500 | High | 2.500 |
Low | 2.410 | Buy | 2.410 |
Sell | 2.420 | Trade | 556 |
Value | 2,551,395.00 | Buy Qty | 68,500 |
Sell Qty | 200 | Total Buy Vol | 472,700 |
Total Buy Trans | 43 | Total Sell Vol | 695,600 |
Total Sell Trans | 309 | Share Issue | 706,330,193 |
Market Cap | 1,702,255,765.13 | Ceiling | 3.25 |
Floor | 1.75 | PVWAP | 0 |
Unit | 900 | NTA | 0.900 |
EPS | 0 | Board | MAIN |
Sector | HEALTH CARE | ISIN | MYL7148OO009 |
Latest Announcements for DPHARMA
Date | Category | Title |
---|---|---|
29/08/2022 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) |
29/08/2022 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) |
22/08/2022 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) |
19/08/2022 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) |
19/08/2022 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) |
18/08/2022 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) |
18/08/2022 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) |
17/08/2022 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) |
17/08/2022 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) |
16/08/2022 | General Announcement for PLC | OTHERS DUOPHARMA BIOTECH DELIVERS BETTER EARNINGS IN 2Q 2022 |